blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3612167

EP3612167 - PROCESS FOR PREPARING AN ORAL DISINTEGRATING DOSAGE FORM [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  12.01.2024
Database last updated on 14.06.2024
FormerRequest for examination was made
Status updated on  24.01.2020
FormerThe international publication has been made
Status updated on  27.10.2018
Most recent event   Tooltip05.06.2024New entry: Additional fee for renewal fee: despatch of communication + time limit 
Applicant(s)For all designated states
Zeenar Enterprises Pty Ltd
Suite 4
419 Bay Street
Brighton, Victoria 3186 / AU
[2020/09]
Inventor(s)01 / MADMON, Tomer
c/- Suite 4, 419 Bay Street
Brighton, Victoria 3186 / AU
02 / KANNAR, David
c/- Suite 4, 419 Bay Street
Brighton, Victoria 3186 / AU
 [2020/09]
Representative(s)V.O.
P.O. Box 87930
2508 DH Den Haag / NL
[2020/09]
Application number, filing date18788561.120.04.2018
[2020/09]
WO2018AU50364
Priority number, dateAU2017090144320.04.2017         Original published format: AU 2017901443
AU2018090079109.03.2018         Original published format: AU 2018900791
[2020/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018191792
Date:25.10.2018
Language:EN
[2018/43]
Type: A1 Application with search report 
No.:EP3612167
Date:26.02.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 25.10.2018 takes the place of the publication of the European patent application.
[2020/09]
Search report(s)International search report - published on:AU25.10.2018
(Supplementary) European search report - dispatched on:EP29.01.2021
ClassificationIPC:A61K9/20, A61K9/107, A61K9/127, A61K31/505, A61K47/10, A61K47/12, A61K47/14, A61K31/40
[2021/09]
CPC:
A61K9/0056 (EP); A61K9/006 (US); A61K31/137 (US);
A61K31/40 (EP,US); A61K31/485 (US); A61K31/505 (EP,US);
A61K47/10 (EP); A61K47/12 (EP); A61K47/14 (EP);
A61K9/107 (EP); A61K9/127 (EP); A61K9/2009 (US);
A61K9/2013 (US); A61K9/2018 (US); A61K9/2027 (US);
A61K9/2059 (US); A61K9/2095 (US) (-)
Former IPC [2020/09]A61K9/20, A61K9/107, A61K9/127, A61K47/10, A61K47/12, A61K47/14, A61K31/505
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/09]
TitleGerman:VERFAHREN ZUR HERSTELLUNG EINER IM MUND ZERFALLENDEN DARREICHUNGSFORM[2020/09]
English:PROCESS FOR PREPARING AN ORAL DISINTEGRATING DOSAGE FORM[2020/09]
French:PROCÉDÉ DE PRÉPARATION D'UNE FORME POSOLOGIQUE À DÉSINTÉGRATION ORALE[2020/09]
Entry into regional phase20.11.2019National basic fee paid 
20.11.2019Search fee paid 
20.11.2019Designation fee(s) paid 
20.11.2019Examination fee paid 
Examination procedure20.11.2019Examination requested  [2020/09]
03.08.2021Amendment by applicant (claims and/or description)
12.01.2024Despatch of a communication from the examining division (Time limit: M06)
Fees paidRenewal fee
27.04.2020Renewal fee patent year 03
29.04.2021Renewal fee patent year 04
25.04.2022Renewal fee patent year 05
25.04.2023Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.04.202407   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2015189726  (CAPSUGEL BELGIUM NV [BE]) [X] 1-15* examples *
International search[X]WO2007031801  (PHARMATHEN SA [GR], et al) [X] 1, 5-11, 14, 15 * Page 1, Lines 9-13; Page 11 & Table 3; and, Examples *;
 [X]WO2008002529  (CAPRICORN PHARMA INC [US], et al) [X] 1-3, 5-15 * See Example 1 and Page 21, Lines 14-16 *;
 [X]US2010010101  (CHERUKURI S RAO [US]) [X] 1-3, 5-22 * See Paragraphs [0098] & [0154]; Examples 1-3, 10, 24 *;
 [X]WO2014179845  (ZEENAR ENTPR PTY LTD [AU]) [X] 1-22 * See Whole Document *;
 [X]EP2826465  (SANOVEL ILAC SANAYI VE TICARET [TR]) [X] 1-3, 5-12, 14, 15 * See Examples & Claims *;
 [X]WO2015176008  (VIVUS INC [US]) [X] 1-3, 5-11, 13-15 * Abstract; Paragraphs [0075], [0081], [0089]; Example 6 *;
 [X]WO2016053092  (OXYTONE BIOSCIENCE B V [NL]) [X] 1, 5-11, 14, 15 * See Abstract and Example 5 *;
 [X]WO2016069871  (JOHNSON & JOHNSON CONSUMER INC [US]) [X] 1-22 * Paragraph [00126]; and, Examples 1 and 2 *;
 [X]WO2017017679  (DEXCEL PHARMA TECHNOLOGIES LTD [IL]) [X] 1-3, 5-12, 14, 15 * See Page 7, Lines 18-22; Example 1, Tables 1-4; Example 3 *;
 [X]  - MOEBUS et al., "Cubic phase-forming dry powders for controlled drug delivery mucosal surfaces", Journal of Controlled Release, (20120000), vol. 157, no. 2, pages 206 - 215, XP028442122 [X] 1-22 * Whole Document *

DOI:   http://dx.doi.org/10.1016/j.jconrel.2011.09.075
 [X]  - SOUZA et al., "Mucoadhesive System Formed by Liquid Crystals for Bucca Administration of Poly(Hexamethylene Biguanide) Hydrochloride", Journal Pharmaceutical Sciences, (20140101), vol. 103, no. 12, doi:10.1002/jps.24198, ISSN 0022-3549, pages 3914 - 3923, XP055645887 [X] 1-22 * See Title; Abstract; Heading "Preparation of Liquid Crystalline Systems of GMO and Water"; and, Results *

DOI:   http://dx.doi.org/10.1002/jps.24198
 [X]  - DU et al., "A novel approach to enhance the mucoadhesion of lipid drug nanocarriers fo improved drug delivery to the buccal mucosa", International Journal of Pharmaceutic, (20140000), vol. 471, pages 358 - 365, XP028872264 [X] 1-22 * See Abstract; Materials and Methods; and, Results *

DOI:   http://dx.doi.org/10.1016/j.ijpharm.2014.05.044
 [A]  - PAN et al., "Nanostructed Cubosomes as Advanced Drug Delivery System", Current Pharmaceutical Design, (20130000), vol. 19, pages 6290 - 6297, XP055557473 [A] 0

DOI:   http://dx.doi.org/10.2174/1381612811319350006
 [A]  - PURATCHIKODY et al., "Buccal Drug Delivery: Past, Present and Future - A Review", International Journal of Drug Delivery, (20110000), vol. 3, no. 2, pages 171 - 184, XP055139193 [A] 0
 [XP]  - GABR et al., "Hexagonal Liquid Crystalline Nanodispersions Proven Superiority for Enhanced Oral Delivery of Rosuvastatin: In Vitro Characterization and In Vivo Pharmacokinetic Study", Journal of Pharmaceutical Sciences, (20171001), vol. 106, no. 10, doi:10.1016/j.xphs.2017.04.060 0, ISSN 0022-3549, pages 3103 - 3112, XP055645888 [X] 11, 13 * See Whole Document See Whole Document * [PX] 1-10, 12, 14-22

DOI:   http://dx.doi.org/10.1016/j.xphs.2017.04.060
 [A]  - DAVIES, J.T., "A quantitative kinetic theory of emulsion type, I. Physical chemistry of the emulsifying agent", Gas/Liquid and Liquid/Liquid Interface, Proceedings of the 2nd International Congress of Surface Activity, Butterworths, London, (19570000), pages 426 - 438, URL: http://www.firp.ula.ve/archivos/historicos/57_ChapDavies.pdf, (20180621), XP000869825 [A] 0 * . Page 430, Equation (9); and Page 431, Table III *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.